Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration

Journal of the American College of Surgeons

Volumn 215, Issue 1, 2012, Pages 41-51

  Truty, Mark J ^a   Thomas, Ryan M ^a   Katz, Matthew H ^a   Vauthey, Jean Nicolas ^a   Crane, Christopher ^a   Varadhachary, Gaury R ^a   Wolff, Robert A ^a   Abbruzzese, James L ^a   Lee, Jeffrey E ^a   Fleming, Jason B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BILE DUCT BYPASS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

CARCINOMA, PANCREATIC DUCTAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES;

EID: 84862999224     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.03.024     Document Type: Article

References (28)

1. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10:1199-1210; discussion 1210-1211.
2. Hartel M, Niedergethmann M, Farag-Soliman M, et al. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168:707-712. (Pubitemid 36609524)
3. Lu DS, Reber HA, Kadell BM, et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Rentgenol 1997;168:1439-1443. (Pubitemid 27232661)
4. Tamm EP, Loyer EM, Faria S, et al. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 2006;31:568-574. (Pubitemid 46360846)
5. Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008;206:833-846; discussion 846-848.
6. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335-1339.
7. Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26: 3496-3502.
8. Pisters PW, Wolff RA, Janjan NA, et al. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol 2002;20:2537-2544. (Pubitemid 34525741)
9. Varadhachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26:3487-3495.
10. Nakagohri T, Kinoshita T, Takahashi S, et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003;186: 149-153. (Pubitemid 37289087)
11. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004;8:935-949; discussion 949-950.
12. Hwang RF, Wang H, Lara A, et al. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 2008;15:1356-1366.
13. Winchester DP, Stewart AK, Jones RS, et al. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 2004;85:1-3. (Pubitemid 38036733)
14. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 2006;13:1035-1046. (Pubitemid 44337962)
15. Yen TW, Abdalla EK, Evans DB, et al. Pancreaticoduodenectomy. In: Von Hoff DD, Evans DB, Hruban RH, eds. Pancreatic Cancer. Sudbury, MA: Jones and Bartlett; 2005: 265.286.
16. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007;246:52-60. (Pubitemid 47012207)
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213. (Pubitemid 38963009)
18. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy. Ann Surg 1994;219:211-221. (Pubitemid 24064079)
19. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 2009;16:836-847.
20. Hashimi H. Reoperative pancreaticoduodenectomy. Ann Surg 1995;221:121-122.
21. Lavu H, Nowcid LJ, Klinge MJ, et al. Reoperative completion pancreatectomy for suspected malignant disease of the pancreas. J Surg Res 2011;170:89-95.
22. Robinson EK, Lee JE, Evans DB, et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996;172:432-437; discussion 437-438.
23. Shukla PJ, Qureshi SS, Desouza LJ, et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. ANZ J Surg 2005;75:520-523. (Pubitemid 41002551)
24. Lee JK, Kim AY, Ha HK, et al. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma. Eur J Radiol 2010;73:310-316.
25. Loyer EM, David CL, Charnsangavej C, et al. Vascular involvement in pancreatic adenocarcinoma: reassessment by thinsection CT. Abdom Imaging 1996;21:202-206.
26. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thinsection contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994;167:104-111; discussion 111-113.
27. Chandler NM, Canete JJ, Stuart KE, Callery MP. Preoperative chemoradiation in resectable pancreatic cancer. J Hepatobiliary Pancreat Surg 2003;10:61-66. (Pubitemid 36850305)
28. Satoi S, Yanagimoto H, Toyokawa H, et al. Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas 2009;38:282-288.